These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 12468169)

  • 1. Relationship between maternal methadone dosage and neonatal withdrawal.
    Dashe JS; Sheffield JS; Olscher DA; Todd SJ; Jackson GL; Wendel GD
    Obstet Gynecol; 2002 Dec; 100(6):1244-9. PubMed ID: 12468169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of factors that influence the severity of neonatal narcotic withdrawal.
    Ostrea EM; Chavez CJ; Strauss ME
    Addict Dis; 1975; 2(1-2):187-99. PubMed ID: 1163362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal methadone dose and neonatal withdrawal.
    Berghella V; Lim PJ; Hill MK; Cherpes J; Chennat J; Kaltenbach K
    Am J Obstet Gynecol; 2003 Aug; 189(2):312-7. PubMed ID: 14520184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome.
    Pritham UA; Paul JA; Hayes MJ
    J Obstet Gynecol Neonatal Nurs; 2012 Mar; 41(2):180-190. PubMed ID: 22375882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neonatal abstinence syndrome and maternal toxicological profile].
    Fundarò C; Solinas A; Martino AM; Genovese O; Noia G; Conte GL; Segni G
    Minerva Pediatr; 1994 Mar; 46(3):83-8. PubMed ID: 8035762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.
    Liu AJ; Jones MP; Murray H; Cook CM; Nanan R
    Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):253-8. PubMed ID: 20618243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance use in pregnancy.
    Wong S; Ordean A; Kahan M; ; ; ; ;
    J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources.
    Arlettaz R; Kashiwagi M; Das-Kundu S; Fauchère JC; Lang A; Bucher HU
    Acta Obstet Gynecol Scand; 2005 Feb; 84(2):145-50. PubMed ID: 15683374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal methadone dosage and neonatal withdrawal.
    Malpas TJ; Darlow BA; Lennox R; Horwood LJ
    Aust N Z J Obstet Gynaecol; 1995 May; 35(2):175-7. PubMed ID: 7677682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal.
    Doberczak TM; Kandall SR; Friedmann P
    Obstet Gynecol; 1993 Jun; 81(6):936-40. PubMed ID: 8497359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The obstetrical and neonatal impact of maternal opioid detoxification in pregnancy.
    Stewart RD; Nelson DB; Adhikari EH; McIntire DD; Roberts SW; Dashe JS; Sheffield JS
    Am J Obstet Gynecol; 2013 Sep; 209(3):267.e1-5. PubMed ID: 23727040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid Utilization by Pregnant Women with Sickle Cell Disease and the Risk of Neonatal Abstinence Syndrome.
    Nnoli A; Seligman NS; Dysart K; Baxter JK; Ballas SK
    J Natl Med Assoc; 2018 Apr; 110(2):163-168. PubMed ID: 29580450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal outcome in narcotic-dependent women: the importance of the type of maternal narcotic used.
    Stimmel B; Goldberg J; Reisman A; Murphy RJ; Teets K
    Am J Drug Alcohol Abuse; 1982-1983; 9(4):383-95. PubMed ID: 7188001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome.
    Isemann B; Meinzen-Derr J; Akinbi H
    J Perinatol; 2011 Jan; 31(1):25-9. PubMed ID: 20508596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?].
    Bläser A; Pulzer F; Knüpfer M; Robel-Tillig E; Vogtmann C; Nickel P; Kiess W
    Klin Padiatr; 2008; 220(5):308-15. PubMed ID: 18260044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone maintenance program in a Swiss perinatal center: (I): Management and outcome of 89 pregnancies.
    Kashiwagi M; Arlettaz R; Lauper U; Zimmermann R; Hebisch G
    Acta Obstet Gynecol Scand; 2005 Feb; 84(2):140-4. PubMed ID: 15683373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of neonatal outcomes amongst a methadone- and/or heroin-dependent population referred to a multidisciplinary Perinatal and Family Drug Health Service.
    Buckley V; Razaghi A; Haber P
    Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):464-70. PubMed ID: 23550533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose methadone in pregnant women and its effect on duration of neonatal abstinence syndrome.
    Lim S; Prasad MR; Samuels P; Gardner DK; Cordero L
    Am J Obstet Gynecol; 2009 Jan; 200(1):70.e1-5. PubMed ID: 18976737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
    Binder T; Vavrinková B
    Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of methadone dose regimen on neonatal abstinence syndrome.
    McCarthy JJ; Leamon MH; Willits NH; Salo R
    J Addict Med; 2015; 9(2):105-10. PubMed ID: 25599433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.